235 related articles for article (PubMed ID: 2445000)
1. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Milani M; Tacconi R; Marsili G; Trognoni A; Centioni G; Leoni T; Fumarola A
Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
[No Abstract] [Full Text] [Related]
2. Prostate cancer-associated markers.
Chu TM
Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
[TBL] [Abstract][Full Text] [Related]
3. [Various immunohistochemical markers of precancer and variants of prostate cancer].
Romanenko AM; Vorob'eva LR
Arkh Patol; 1995; 57(4):38-41. PubMed ID: 8526754
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
Morote Robles J; de Torres Mateos JA; Soler-Roselló A
Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
[No Abstract] [Full Text] [Related]
5. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
Yamaguchi K; Tanaka M; Kitagawa N; Kotake T; Yanagi S; Ito H
Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
7. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
8. Acid phosphatase, alkaline phosphatase and prostate specific antigen: which markers should we choose?
Cooper EH; Siddall JK; Newling DW; Robinson MR
Prog Clin Biol Res; 1988; 269():43-56. PubMed ID: 2455911
[No Abstract] [Full Text] [Related]
9. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
Hübler J; Jávor A
Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
[TBL] [Abstract][Full Text] [Related]
10. Prostate specific antigen. Experimental and clinical observations.
Huber PR; Schnell Y; Hering F; Rutishauser G
Scand J Urol Nephrol Suppl; 1987; 104():33-9. PubMed ID: 2449722
[TBL] [Abstract][Full Text] [Related]
11. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
12. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers in prostate cancer].
Kuriyama M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of prostate-specific antigen (PSA) in prostate tissue: correlation with prostatic acid phosphatase (PAP)].
Morote Robles J; Segura RM; De Torres JA; Soler Roselló A
Actas Urol Esp; 1987; 11(2):180-3. PubMed ID: 2441576
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
Park YC; Kiwamoto H; Nishioka T; Tsujihashi H; Mitsubayashi S; Matsuura T; Akiyama T; Kurita T; Miyamoto T
Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
[TBL] [Abstract][Full Text] [Related]
16. [Significance of prostate fluid carcinoembryonic antigen in the diagnosis of prostate cancer].
Hayashi T; Yamauchi A; Hosoda K
Hinyokika Kiyo; 1995 Jul; 41(7):525-8. PubMed ID: 7545350
[TBL] [Abstract][Full Text] [Related]
17. Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia.
Maygarden SJ
Pathol Annu; 1994; 29 Pt 1():303-20. PubMed ID: 7510385
[No Abstract] [Full Text] [Related]
18. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
Fuse H; Akimoto S; Shimazaki J
Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
[TBL] [Abstract][Full Text] [Related]
20. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
Bauer HW
Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
